Skip to main content

Table 1 Clinical characteristics of the HCC patients used in this study

From: A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma

 

TCGA-LIHC cohort

ICGC-LIRP-JI cohort

No. of patients

209

231

Age (median, range)

59 (16–90)

67 (31–89)

Gender

Female

65 (31.1%)

61 (26.4%)

Male

144 (68.9%)

170 (73.6%)

Grade

Grade 1

35 (16.7%)

NA

Grade 2

103 (49.3%)

NA

Grade 3

62 (29.7%)

NA

Grade 4

7(3.3%)

NA

Unknown

2 (1.0%)

NA

Stage

I

91 (43.5%)

36 (15.6%)

II

54 (25.8%)

105 (45.5%)

III

49 (23.4%)

71 (30.7%)

IV

1 (0.5%)

19 (8.2%)

Unknown

14 (6.7%)

0 (0%)

Survival status

Alive

159 (76.1%)

189 (81.8%)

Deceased

50 (23.9%)

42 (18.2%)

Follow up (median, range)

588 (1–1363)

900 (10–2160)